Biodesix raises $11.7M in private placement, amends term loan again

BOULDER — Biodesix Inc. (Nasdaq: BDSX), a medical diagnostics company that focuses on using artificial intelligence to test for lung disease, raised $11.7 million in a private placement offering. 

The offering involved selling more than 6.5 million shares of common stock at $1.79 per share to members of the company’s board of directors and other existing shareholders.

Biodesix also amended its 2021 term loan, agreeing to repay $3 million this month and $2 million by May 15 in exchange for the following:

• Consent for a $2.0 million April 2022 mutually agreed upon milestone payment under the Integrated Diagnostics Asset Purchase Agreement, as amended.
• Waiver…